286 related articles for article (PubMed ID: 19319532)
1. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Bacher U; Klyuchnikov E; Zabelina T; Ottinger H; Beelen DW; Schrezenmeier H; Ehninger G; Müller C; Berger J; Suttorp M; Kolb HJ; Kröger N; Zander AR
Ann Hematol; 2009 Dec; 88(12):1237-47. PubMed ID: 19319532
[TBL] [Abstract][Full Text] [Related]
2. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
3. Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - a retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry.
Faber E; Koza V; Vitek A; Mayer J; Sedlacek P; Zak P; Zapletalova J; Benesova K; Krejcova H; Steinerova K; Maresova I; Cetkovsky P;
Neoplasma; 2007; 54(5):443-6. PubMed ID: 17688375
[TBL] [Abstract][Full Text] [Related]
4. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
5. Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).
Heinzelmann F; Ottinger H; Müller CH; Allgaier S; Faul C; Bamberg M; Belka C
Strahlenther Onkol; 2006 Apr; 182(4):222-30. PubMed ID: 16622624
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
8. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT.
Reiffers J; Goldman J; Meloni G; Cahn JY; Gratwohl A
Bone Marrow Transplant; 1994 Sep; 14(3):407-10. PubMed ID: 7994263
[TBL] [Abstract][Full Text] [Related]
9. Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético).
Martínez C; Gomez V; Tomás JF; Parody R; Sureda A; Sanz G; Cañizo C; Díez JL; Boqué C;
Bone Marrow Transplant; 2005 Aug; 36(4):301-6. PubMed ID: 15968278
[TBL] [Abstract][Full Text] [Related]
10. Second allogeneic stem cell transplantation in myeloid malignancies.
Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
[TBL] [Abstract][Full Text] [Related]
11. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Burke MJ; Trotz B; Luo X; Weisdorf DJ; Baker KS; Wagner JE; Verneris MR
Bone Marrow Transplant; 2009 Aug; 44(3):169-74. PubMed ID: 19204709
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic stem cell transplantation for chronic myeloid leukemia.
Barrett J
Semin Hematol; 2003 Jan; 40(1):59-71. PubMed ID: 12563612
[TBL] [Abstract][Full Text] [Related]
13. Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries.
Silberman G; Crosse MG; Peterson EA; Weston RC; Horowitz MM; Appelbaum FR; Cheson BD
N Engl J Med; 1994 Oct; 331(16):1063-7. PubMed ID: 8090167
[TBL] [Abstract][Full Text] [Related]
14. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
15. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Oyekunle A; Zander AR; Binder M; Ayuk F; Zabelina T; Christopeit M; Stübig T; Alchalby H; Schafhausen P; Lellek H; Wolschke C; Müller I; Bacher U; Kröger N
Ann Hematol; 2013 Apr; 92(4):487-96. PubMed ID: 23250623
[TBL] [Abstract][Full Text] [Related]
16. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.
Passweg JR; Walker I; Sobocinski KA; Klein JP; Horowitz MM; Giralt SA;
Br J Haematol; 2004 Jun; 125(5):613-20. PubMed ID: 15147377
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress in hematopoietic stem cell transplantation].
Shinagawa K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):727-35. PubMed ID: 16770089
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic significance of EBMT score for chronic myeloid leukemia patients in allogeneic stem cell transplantation].
Hu J; Zhang WP; Yang D; Tang W; Song XM; Wang L; Zhao WL; Wu W; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):75-8. PubMed ID: 21429370
[TBL] [Abstract][Full Text] [Related]
19. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
van der Meer A; Schaap NP; Schattenberg AV; van Cranenbroek B; Tijssen HJ; Joosten I
Mol Immunol; 2008 Aug; 45(13):3631-8. PubMed ID: 18555529
[TBL] [Abstract][Full Text] [Related]
20. [Allogeneic bone marrow transplantation for chronic myeloid leukemia: 118 cases analysis].
Liu D; Guo N; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):424-6. PubMed ID: 11721424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
